Valeant shares dive despite CEO's return from illness

Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker's delayed financial results and its leader's health.

See Full Article

Even news Sunday that CEO Michael Pearson is returning immediately after nine weeks recovering from pneumonia and unspecified complications failed to buoy Valeant shares.

The shares are trading at less than one-third of their $263.81 high last August. That was right before Valeant's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny, and a few months before its questionable relationship with a drug distributor raised concerns about the accuracy of its financial reporting.

Valeant shares dropped $6.75, or 8.4 per cent, to $73.90 in midday trading Monday.

Investors appear to be reacting to Valeant's announcement in a statement Sunday that is withdrawing all its financial forecasts.

Nomura equity analyst Shibani Malhotra wrote Monday that while Pearson's return to the helm "is a positive," for the company, she's concerned by Valeant's decision to withdraw its 2016 guidance, which was confirmed just six weeks ago.

Valeant, based in Laval, Quebec, also again delayed announcing its preliminary fourth-quarter and 2015 financial results, which were to be released Monday. The company cited Pearson's return to work as the reason.

"Valeant won't turn around until it restores its credibility, and it doesn't help to bring back the CEO who created the questions about financial reporting on his watch and his handling of questions about Philidor," Erik Gordon, a professor and pharmaceuticals analyst at University of Michigan's Ross School of Business, wrote in an email.

Pearson's convalescence, and the limited information the company released about his condition, aren't the only concerns dragging down Valeant shares.

Last Tuesday, Valeant said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor. Valeant said it expected to lower reported 2014 earnings by about 10 cents per share and raise 2015 earnings by about 9 cents. That's because about $58 million in sales to Philidor were improperly recognized too early -- when they were delivered to Philidor, rather than when patients received the products.

Moody's Investor's Service on Tuesday revised Valeant's outlook to negative from stable, but noted that the amount of revenue misstated "appears relatively minor."

Valeant cut ties with Philidor last fall amid allegations that Philidor created a network of "phantom pharmacies" to steer pharmacy benefit managers toward Valeant's more-expensive drugs instead of cheaper alternatives.

Responding to public criticism over its huge price increases for some products, Valeant's interim CEO, Howard Schiller, on Feb. 2 told a House committee investigating high drug prices that he froze all of Valeant's price increases when he took over in January. He said Valeant would aim for more modest price increases in the future.

Schiller is to transition out of his temporary CEO duties but remain a member of Valeant's board. The board also decided to split the roles of chairman and CEO, both of which had been held by Pearson, and appoint Robert A. Ingram as chairman of the board. Ingram has been on Valeant's board since 2010 and previously served as chairman for a few months at the start of 2011.

The board said in the statement that planning for Pearson's successor and expanding Valeant's senior management "are high priorities."

Jeffrey Loo, equity analyst at S&P Global Market Intelligence, wrote Monday that "the return of Mr. Pearson and (Valeant's) efforts to build out its management team for succession planning should provide some stability" and that he maintains a "Buy" recommendation on the stock.



Advertisements

Latest Economic News

  • Rivals praise EU ruling against Google

    Economic CTV News
    BRUSSELS - European regulators' latest swipe at the dominance of U.S. tech giant Google could open new opportunities for rivals in search and web browsers - that is, if handset manufacturers decide to make the most of the opening. Source
  • Hydrogen sulfide leak at Suncor refinery sends workers to hospital

    Economic CTV News
    EDMONTON - A number of people at Suncor's refinery in Edmonton were sent to hospital after a toxic gas was released at the facility. Suncor spokeswoman Erin Rees says company crews responded to a release of hydrogen sulfide at around noon on Wednesday. Source
  • Burnaby, B.C. issues eviction notice to Kinder Morgan protesters

    Economic CTV News
    BURNABY, B.C. - The City of Burnaby is evicting protesters from a make-shift camp set up outside one of Kinder Morgan's terminals, citing fire safety and public health concerns. City manager Lambert Chu says the city is worried about how the footprint of the site, dubbed Camp Cloud, has grown to include a two-level wood structure, additional tents and even shower facilities. Source
  • CP Rail second-quarter profit hurt by disruptions related to labour strife

    Economic CBC News
    ?Canadian Pacific Railway Ltd. says service interruptions related to labour negotiations and strike notices caused its net income to decrease 10 per cent in the second quarter despite higher revenues. The Calgary-based railway earned $436 million, compared with $480 million a year earlier. Source
  • CP Rail second-quarter profits hurt by disruptions related to labour strife

    Economic CTV News
    CALGARY -- Canadian Pacific Railway Ltd. says service interruptions related to labour negotiations and strike notices caused its net income to decrease 10 per cent in the second quarter despite higher revenues. The Calgary-based railway earned $436 million, compared with $480 million a year earlier. Source
  • Manitoba will charge 'social responsibility fee' on cannabis retailers

    Economic CTV News
    WINNIPEG -- When recreational cannabis is legalized later this year, it will be subject to a government fee and a wholesale markup in Manitoba. The provincial government says a "social responsibility fee" of six per cent will be applied to a cannabis retailer's total annual revenues. Source
  • Costco launches online grocery delivery in Canada

    Economic CTV News
    Costco.ca is the latest retailer to launch an online grocery store in Canada, starting with some stores in southern Ontario. The membership-based retailer has begun offering hundreds of non-perishable grocery items, beauty products and supplements online. Source
  • Nova Scotia's 'unique' cannabis stores unveiled

    Economic CTV News
    HALIFAX -- The Nova Scotia Liquor Corp. offered a glimpse inside one of its coming cannabis stores Wednesday, showcasing a unique retail hybrid not likely found anywhere else in the world. NSLC president and CEO Bret Mitchell took media on a tour of the cannabis store that's inside the NSLC on Joseph Howe Drive in Halifax, saying Nova Scotia is the only jurisdiction that brings cannabis and alcohol sales under one roof. Source
  • Manitoba Hydro boss announces retirement; says the time is right to leave

    Economic CTV News
    WINNIPEG -- The president and CEO of Manitoba Hydro has announced he is retiring less than three years after joining the Crown corporation. Kelvin Shepherd, who joined the utility in December 2015 after a five-year stint at MTS Inc. Source
  • CRA lawyers say Loblaw misused Barbadian subsidiary for tax avoidance

    Economic CTV News
    TORONTO - Government lawyers say Loblaw Companies Ltd.'s Barbadian banking subsidiary was "playing with its own money" rather than an active business with outside customers and is obligated to pay tax back home. Justice Department lawyer Elizabeth Chasson said in her closing arguments at the Tax Court of Canada that Barbados-based Glenhuron Bank Ltd. Source